MINDY ROMANOV: Open Payments
NPI 1043689763 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,208 in 62 payments from 14 companies in 2025. Trend: 2023 $850 · 2024 $1,274 · 2025 $1,208
Food & beverage: $1,108Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $243 |
| Arcutis Biotherapeutics, Inc. | 12 | $188 |
| ABBVIE INC. | 9 | $154 |
| GENZYME CORPORATION | 5 | $127 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $86 |
| Organon LLC | 4 | $79 |
| Novartis Pharmaceuticals Corporation | 3 | $65 |
| UCB, Inc. | 2 | $63 |
| Cipher Pharmaceuticals US LLC | 1 | $57 |
| LEO Pharma Inc. | 3 | $56 |
Products named: TREMFYA, Zoryve, DUPIXENT, SKYRIZI, Bimzelx, Natroba, ADBRY, NEMLUVIO.
Industry payments across FL — which companies pay providers there.
